The MedTech Revenue Playbook: Driving Growth Before Payer Coverage Catches Up
VCs, acquirers, and bankers all ask one thing: does this company have a revenue machine, even before reimbursement catches up? When investors evaluate a VC-backed medtech company, they are not simply assessing whether reimbursement will eventually arrive. They are evaluating whether the company has already built the infrastructure to achieve revenue during the coverage gap […]
JDL Access, LLC Achieves SOC 2 Type II Certification, Validating the Security Foundation of Its Access Bridge™ Platform
Clearwater, FL May 26th, 2026 – JDL Access, LLC, a specialized provider of end-to-end patient and payer access and reimbursement support services for medical technology and biopharmaceutical companies, today announced it has successfully achieved SOC 2 Type II certification. The certification, conducted by an independent third-party auditor, validates the security, availability, and confidentiality controls underpinning […]
The Buy vs. Build Decision: Choosing the Right Patient Access Program Strategy for Your Medical Technology
The promise of an in-house patient access program is compelling: greater control, deeper provider relationships, and a direct hand in getting patients to therapy faster. But the path from vision to execution is lined with decisions that can make or break the effort. We offer some suggestions for consideration based on our experience. For medical […]
Two Systemic Barriers Blocking Access to Cutting-Edge Medical Technologies
Medical innovation outpaces medical policy with health insurance plans. That reality can be difficult to accept for companies that have poured significant investment into a new device, drug, or biologic. For health plans, FDA marketing authorization is important, but other factors are essential: long-term data, medical society guidelines, provider utilization, etc. Until those factors are […]
Prior Authorization: When the Burden Becomes the Bridge
Patient access isn’t just reimbursement mechanics — it’s the infrastructure that determines whether life-changing innovation actually reaches patients. Ironically, the burden of a prior authorization denial is the only bridge to a coverage decision that could change everything. The challenge isn’t defending administrative burden. It’s making sure the bridge doesn’t get demolished before patients have […]
Why Your Medical Device Needs a Patient Access Program
You’ve done the hard work. Your medical device has FDA clearance or approval. Clinical data supports its efficacy. Providers are interested. And yet, patients are being denied coverage and adoption is stalling. Two of the most common and misunderstood barriers in medical device market access are silent medical policy (no policy on file) and Experimental […]